ZyVersa Therapeutics Statistics
Total Valuation
ZVSA has a market cap or net worth of 696,905. The enterprise value is -914,625.
| Market Cap | 696,905 |
| Enterprise Value | -914,625 |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVSA has 4.87 million shares outstanding. The number of shares has increased by 601.10% in one year.
| Current Share Class | 4.87M |
| Shares Outstanding | 4.87M |
| Shares Change (YoY) | +601.10% |
| Shares Change (QoQ) | +56.03% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 1.44% |
| Float | 4.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.10 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.72 |
Financial Efficiency
Return on equity (ROE) is -91.39% and return on invested capital (ROIC) is -54.61%.
| Return on Equity (ROE) | -91.39% |
| Return on Assets (ROA) | -24.79% |
| Return on Invested Capital (ROIC) | -54.61% |
| Return on Capital Employed (ROCE) | -94.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.26M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVSA has paid 6,745 in taxes.
| Income Tax | 6,745 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.71% in the last 52 weeks. The beta is 0.82, so ZVSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -96.71% |
| 50-Day Moving Average | 0.60 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 22.28 |
| Average Volume (20 Days) | 12,407,129 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.45M |
| Pretax Income | -8.84M |
| Net Income | -8.84M |
| EBITDA | -8.45M |
| EBIT | -8.45M |
| Earnings Per Share (EPS) | -5.11 |
Balance Sheet
The company has 1.61 million in cash and n/a in debt, giving a net cash position of 1.61 million or 0.33 per share.
| Cash & Cash Equivalents | 1.61M |
| Total Debt | n/a |
| Net Cash | 1.61M |
| Net Cash Per Share | 0.33 |
| Equity (Book Value) | 8.13M |
| Book Value Per Share | 3.17 |
| Working Capital | -9.89M |
Cash Flow
| Operating Cash Flow | -5.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZVSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -601.10% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,268.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |